Latest filing published 16 Feb 2024 for CERO THERAPEUTICS HOLDINGS, INC..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Phoenix Biotech Sponsor, LLC: trading record in brief
Phoenix Biotech Sponsor, LLC discloses dealings in Cero Therapeutics Holdings, Inc. to SEC (Form 4). Between 8 October 2021 and 14 February 2024, the trades on record add up to 3 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 16 February 2024, reports a transaction in Cero Therapeutics Holdings, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Phoenix Biotech Sponsor, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,125,000 sharesCommon StockSEC:0001213900-24-015028:0
- 36,733 shares@ US$10.00100.0% of flowClass A common stockSEC:0000899243-21-039943:0
2 of 2 declarations